From: Optimisation of the RT-PCR detection of immunomagnetically enriched carcinoma cells
 | MDA-MB-468 | MDA-MB-453 | MDA-MB-453 | MDA-MB-453 | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
 | 1 | 2 | 3 | 4 | 5 | 1 | 2 | 3 | 4 | 5 | 1 | 2 | 3 | 4 | 5 | 1 | 2 | 3 | 4 | 5 |
ELF3 | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + |
EphB4 | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | - |
EpCam | + | + | + | + | + | Â | Â | Â | Â | Â | + | + | + | + | + | + | + | + | + | + |
EGFR | + | + | + | + | + | + | - | - | + | + | - | + | - | + | - | + | + | - | - | - |
MGB1 | - | - | - | - | - | Â | Â | Â | Â | Â | - | - | - | + | - | + | - | - | + | + |
 | T-47D | T-47D | T-47D | T-47D | ||||||||||||||||
 | 1 | 2 | 3 | 4 | 5 | 1 | 2 | 3 | 4 | 5 | 1 | 2 | 3 | 4 | 5 | 1 | 2 | 3 | 4 | 5 |
ELF3 | + | + | + | + | + | Â | Â | Â | Â | Â | + | + | + | + | + | + | + | - | + | - |
EphB4 | + | + | + | + | + | - | + | + | - | + | + | + | + | + | + | + | + | - | + | - |
EpCam | + | + | + | + | + | + | + | + | + | + | + | - | + | + | + | + | + | + | + | - |
EGFR | - | - | - | - | - | - | + | - | - | - | - | - | - | - | + | + | + | + | - | - |
MGB1 | - | - | - | - | - | - | - | - | + | + | - | - | - | - | - | + | + | - | - | - |
 | MCF-7 | MCF-7 |  |  |  |  |  |  |  |  |  |  | ||||||||
 | 1 | 2 | 3 | 4 | 5 | 1 | 2 | 3 | 4 | 5 |  |  |  |  |  |  |  |  |  |  |
ELF3 | + | + | + | + | + | + | + | + | + | + | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
EphB4 | - | + | + | + | + | - | + | - | + | - | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
EpCam | - | + | + | - | + | + | + | - | + | + | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
EGFR | - | + | - | - | - | + | - | - | - | - | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
MGB1 | - | - | - | - | - | - | - | - | - | - | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |